An acylated peptide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Myr5A Peptide

Item No. 40257

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • Myristic Acid 5A Peptide
Formula Weight
4428.0
Formulation (Request formulation change)
1 mg of lyophilized peptide
Peptide Sequence
Myr-DWLKAFYDKVAEKLKEAFPDWAKAAYDKAAEKAKEAA (Myr=myristic acid)
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $262

    Add
    Cayman Chemical
    Visit Our Lipid Nanoparticle Resource Center for Additional Tools & Resources
    EXPLORE NOW
    Product Description

    Myr5A peptide is an acylated peptide composed of the apolipoprotein A1 (ApoA1) mimetic peptide 5A peptide conjugated to the saturated fatty acid myristic acid (Item No. 13351).1 It self-assembles into lipid nanostructures and has been used to encapsulate the anthracyclines doxorubicin (Item No. 15007) and valrubicin (Item No. 22964) for in vitro compound-release studies.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Raut, S., Garud, A., Nagarajan, B., et al. Probing the assembly of HDL mimetic, drug carrying nanoparticles using intrinsic fluorescence. J. Pharmacol. Exp. Ther. 373(1), 113-121 (2020).